ANI PHARMACEUTICALS INC
ANIPNASDAQ🏆 #2043 by market capEarnings Nov 5US Equity
$74.62▲ $0.09 (+0.12%)
Live1h▲ 0.6%
24h▲ 0.1%
7d▼ 6.7%
14d▼ 8.8%
30d▼ 8.0%
1y▼ 15.5%
🏦Market Cap
$1.70B
Small Cap
📈Revenue Growth (YoY)
+43.8%
High Growth
📊Gross Margin
65.2%
High
💵FCF Margin
16.3%
Healthy
⚖️P/S Ratio
1.7x
Cheap
Otter Score
45
Weak
📊
Analyst Ratings
Price
$74.62
Total
10
Raised
1
Lowered
2
Avg PT
$104.50
H / L
$119 / $90
| Institution | Action | Rating | Date |
|---|---|---|---|
Guggenheim | Reiterated | Buy | 2026-07-10 |
Truist Securities | Reiterated | Hold | 2025-10-09 |
JP Morgan | Reiterated | Overweight | 2025-09-24 |
HC Wainwright & Co. | Reiterated | Buy | 2025-09-17 |
Raymond James | Reiterated | Outperform | 2024-09-18 |
Cantor Fitzgerald | Downgraded | Overweight → Neutral | 2020-05-07 |
Canaccord Genuity | Reiterated | Buy | 2018-11-12 |
Oppenheimer | Reiterated | Outperform | 2016-08-05 |
Standpoint Research | Downgraded | Buy → Hold | 2016-05-24 |
Roth Capital | Upgraded | Neutral → Buy | 2015-09-28 |
One row per institution, most recent rating